Nasdaq: MEDS

DataMeds AI, Inc. (MEDS)

DataMeds AI, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker MEDS. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
MEDS
Exchange
Nasdaq
SEC CIK
2030763
Official filings
SEC EDGAR

Research MEDS

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is DataMeds AI, Inc.'s stock ticker?

DataMeds AI, Inc. trades under the ticker symbol MEDS on Nasdaq. Its SEC Central Index Key (CIK) is 2030763.

Where can I read DataMeds AI, Inc.'s SEC filings?

The MEDS SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports DataMeds AI, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze MEDS's financial statements?

The MEDS Financials page shows DataMeds AI, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does MEDS compare with its peers and the market?

The MEDS Peer Comparison page lines DataMeds AI, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.